Synopsys (SNPS) Stock Looks Below Fair Value On A 33% Slump

Synopsys stock has fallen 33.5% over the past year, yet its valuation checks send mixed signals, with a Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market multiples suggest the shares are priced at a premium.

• The share price decline of 33.5% over the last 12 months raises the question of whether recent weakness has already accounted for investors’ concerns.
• Growth in AI driven chip design tools and deeper partnerships with large semiconductor and cloud players may support expectations for future cash flows, while legal disputes and integration risks from the Ansys acquisition can weigh on how much investors are willing to pay for that growth.
• On Simply Wall St’s checks, Synopsys scores 3 out of 6 on valuation, which points to a mixed picture rather than a clear bargain or clear overvaluation.

The stock’s next move may depend on whether you put more weight on the intrinsic value suggested by the DCF or on the richer signal coming from earnings based multiples.

Find out why Synopsys' -33.5% return over the last year is lagging behind its peers.

Is Synopsys Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) approach estimates what Synopsys is worth today based on the cash it is expected to generate for shareholders over time. The model uses latest twelve month free cash flow of about $2.6b and then assumes that cash flows keep growing rather than shrinking, which suits a business built around long term software and intellectual property contracts.

On those assumptions, the DCF model points to an intrinsic value of about $511 per share. Compared with the current market price, this implies the stock screens roughly 22.1% undervalued. Recent news about Synopsys expanding its agentic AI chip design tools with major partners is one factor that helps explain why cash flow expectations embedded in the model remain supportive even as the share price has weakened.

Taken together, the discounted cash flow work indicates that Synopsys stock currently appears undervalued relative to its projected cash generation.

Our Discounted Cash Flow (DCF) analysis suggests Synopsys is undervalued by 22.1%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Is Synopsys Getting Expensive on Earnings?

P/E is often the go-to multiple for a software business like Synopsys because earnings are a key focus for many investors. On this measure, Synopsys trades on a P/E of about 98.5x, which is well above the wider software industry average of around 30.6x and also above the peer group average of about 33.9x.

Simply Wall St’s model suggests a fair P/E ratio of roughly 51.2x for Synopsys, based on its mix of growth profile, margins, size, and risk factors. The gap between the current P/E and this fair ratio implies that the stock screens overvalued on earnings, even after taking into account company-specific characteristics.

On the P/E multiple, Synopsys stock currently looks overvalued relative to both its own fair ratio and broader software peers.

See what the numbers say about this price — find out in our valuation breakdown.

The Synopsys Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Synopsys are meant to connect the valuation puzzle above with the specific assumptions that would need to hold for Synopsys' stock to be worth materially more or materially less than today's price, based on factors like growth, margins, and earnings. Each Narrative sets out a fair value as a thesis about the business that you can revisit over time, and they are hosted on Simply Wall St's Community page.

If you have a clear, number driven view on whether Synopsys' agentic AI chip design push with Microsoft, AMD, Nvidia and Intel delivers on expectations, now is a good time to share a Narrative in the Simply Wall St community and spell out your thesis.

Set out the assumptions you think matter most, track how they line up with future results, and see how your view compares with other Synopsys Narratives over time.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

The Bottom Line

Synopsys sits between two valuation stories. The Discounted Cash Flow (DCF) view points to meaningful upside from here based on projected cash generation, while the P/E based read flags the stock as overvalued against both its own fair ratio and software peers. That split mainly comes down to how much you trust long term cash flow assumptions versus today’s rich earnings multiple and current sentiment. The key question now is whether Synopsys can deliver on its AI related growth ambitions and manage legal and integration risks well enough to justify holding a premium earnings multiple over time.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com